Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Retatrutide (5mg-10mg), Triple Incretin Receptor Agonist Engineered Engagement of GLP-1, GIP, and Glucagon Receptors Introduction Engineered Engagement of GLP-1, GIP, and Glucagon Receptors Retatrutide is a synthetic 39-residue peptide engineered as a balanced agonist of three distinct class B G protein-coupled receptors: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR)
Dysbiosis Altered microbial metabolism may increase endotoxin and other compounds delivered directly to the liver through the portal vein
This triple receptor activation distinguishes it from older medications that target only one or two
405 Differential expression analysis showed downregulation of adhesion/metabolic proteins and upregulation of immune evasion markers, motility proteins, and chromatin regulators, collectively driving invasive and resistant phenotypes
LiveWell supplies it as a synthetic research-grade compound strictly for laboratory and in-vitro scientific research
US$ 25.37
US$ 21.03
US$ 22.65
US$ 25.69
US$ 26.54
